Total Payments
$293,155
2024 Payments
$7,162
Companies
84
Transactions
2,240
Medicare Patients
3,925
Medicare Billing
$370,688
Payment Breakdown by Category
Other$234,319 (79.9%)
Food & Beverage$38,154 (13.0%)
Travel$11,981 (4.1%)
Consulting$8,075 (2.8%)
Education$626.53 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $232,669 | 151 | 79.4% |
| Food and Beverage | $38,154 | 1,999 | 13.0% |
| Travel and Lodging | $11,981 | 64 | 4.1% |
| Consulting Fee | $8,075 | 10 | 2.8% |
| Honoraria | $1,650 | 1 | 0.6% |
| Education | $626.53 | 15 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $80,189 | 103 | $0 (2024) |
| EMD Serono, Inc. | $42,993 | 230 | $0 (2024) |
| GENZYME CORPORATION | $37,726 | 95 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $34,575 | 205 | $0 (2024) |
| ABBVIE INC. | $23,650 | 134 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $21,085 | 43 | $0 (2019) |
| Acorda Therapeutics, Inc | $15,572 | 44 | $0 (2023) |
| Allergan, Inc. | $8,705 | 60 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $5,159 | 155 | $0 (2024) |
| Biogen, Inc. | $3,147 | 201 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,162 | 258 | E.R. Squibb & Sons, L.L.C. ($1,714) |
| 2023 | $5,712 | 248 | AbbVie Inc. ($1,184) |
| 2022 | $18,084 | 294 | ABBVIE INC. ($9,596) |
| 2021 | $29,133 | 294 | AbbVie Inc. ($12,409) |
| 2020 | $43,659 | 225 | Amgen Inc. ($23,306) |
| 2019 | $74,225 | 292 | Amgen Inc. ($47,197) |
| 2018 | $46,359 | 292 | EMD Serono, Inc. ($10,079) |
| 2017 | $68,821 | 337 | GENZYME CORPORATION ($26,029) |
All Payment Transactions
2,240 individual payment records from CMS Open Payments — Page 1 of 90
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Neurology | ||||||
| 12/19/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Immunology | ||||||
| 12/17/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.79 | General |
| 12/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/13/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $71.62 | General |
| Category: Neurology | ||||||
| 12/10/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.71 | General |
| 12/09/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/03/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $42.66 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 12/03/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 12/03/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/26/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/25/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/22/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Neurology | ||||||
| 11/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.89 | General |
| 11/15/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Neurology | ||||||
| 11/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 952 | 1,121 | $229,096 | $90,182 |
| 2022 | 10 | 900 | 1,077 | $224,776 | $90,950 |
| 2021 | 17 | 1,070 | 1,300 | $248,549 | $100,171 |
| 2020 | 16 | 1,003 | 1,218 | $235,125 | $89,386 |
Total Patients
3,925
Total Services
4,716
Medicare Billing
$370,688
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 206 | 314 | $51,948 | $22,354 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 252 | 283 | $39,273 | $15,373 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 178 | $35,782 | $14,709 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $22,377 | $8,521 | 38.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 84 | 85 | $22,264 | $8,114 | 36.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 40 | 40 | $16,502 | $5,776 | 35.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 40 | 40 | $14,191 | $5,088 | 35.9% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 19 | 19 | $8,948 | $3,094 | 34.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 27 | $7,392 | $3,048 | 41.2% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 29 | 29 | $6,330 | $2,316 | 36.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,871 | $1,192 | 41.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 13 | 14 | $1,218 | $597.38 | 49.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 166 | 266 | $45,600 | $19,594 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 253 | 300 | $41,782 | $17,760 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 179 | $36,530 | $15,305 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 118 | 118 | $34,840 | $14,242 | 40.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 49 | 49 | $17,956 | $6,440 | 35.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 63 | 63 | $16,841 | $5,544 | 32.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 34 | 34 | $14,774 | $5,104 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 33 | $9,063 | $4,097 | 45.2% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 18 | 18 | $4,057 | $1,538 | 37.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $3,333 | $1,325 | 39.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 273 | 325 | $45,471 | $20,052 | 44.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 162 | 241 | $40,997 | $18,237 | 44.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 118 | 136 | $27,816 | $11,613 | 41.7% |
About Dr. Howard Schecht, MD
Dr. Howard Schecht, MD is a Neurology healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710984711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Schecht, MD has received a total of $293,155 in payments from pharmaceutical and medical device companies, with $7,162 received in 2024. These payments were reported across 2,240 transactions from 84 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($232,669).
As a Medicare-enrolled provider, Schecht has provided services to 3,925 Medicare beneficiaries, totaling 4,716 services with total Medicare billing of $370,688. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Toledo, OH
- Active Since 07/05/2005
- Last Updated 06/15/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1710984711
Products in Payments
- Aimovig (Biological) $76,734
- AUBAGIO (Drug) $37,257
- UBRELVY (Drug) $30,674
- Rebif (Biological) $24,080
- ACTHAR (Biological) $21,116
- AMPYRA (Drug) $15,277
- AJOVY (Biological) $14,773
- AJOVY (Drug) $11,239
- Mavenclad (Biological) $10,772
- Mavenclad (Drug) $5,490
- COPAXONE (Drug) $3,519
- ZEPOSIA (Drug) $2,529
- RYTARY (Drug) $2,372
- TYSABRI (Biological) $2,326
- KESIMPTA (Drug) $1,390
- NUPLAZID (Drug) $1,100
- Apokyn (Drug) $972.19
- QULIPTA (Drug) $950.29
- GILENYA (Drug) $835.49
- MAVENCLAD (Drug) $819.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Toledo
Mr. Lawrence Elmer, M.d, M.D
Neurology — Payments: $795,067
Neurology $795,067
Dr. Faizan Hafeez, Md, MD
Neurology — Payments: $379,965
Neurology $379,965
Purvi Saraiya, Md, MD
Neurology — Payments: $31,205
Neurology $31,205
Syed Zaidi, M.d, M.D
Neurology — Payments: $29,475
Neurology $29,475
Dr. Gretchen Tietjen, M.d, M.D
Neurology — Payments: $20,256
Neurology $20,256
Mrs. Jennifer Amsdell, M.d, M.D
Neurology — Payments: $17,470
Neurology $17,470